General Information of the Compound
Compound ID |
CP0435726
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2S)-2-[3-[3-cyclopropyl-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide;hydrochloride
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H25ClF3N5O2
|
||||||||||||||||||
Molecular Weight |
507.944
|
||||||||||||||||||
Canonical SMILES |
Cl.NC(=N)N1CCC[C@H]1c1nc(no1)-c1ccc(OCc2ccc(cc2)C(F)(F)F)c(c1)C1CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H24F3N5O2.ClH/c25-24(26,27)17-8-3-14(4-9-17)13-33-20-10-7-16(12-18(20)15-5-6-15)21-30-22(34-31-21)19-2-1-11-32(19)23(28)29;/h3-4,7-10,12,15,19H,1-2,5-6,11,13H2,(H3,28,29);1H/t19-;/m0./s1
Show/Hide
|
||||||||||||||||||
InChIKey |
AHUDPASSTZLZOH-FYZYNONXSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01766, Sphingosine kinase 1
Protein ID: PT01765, Sphingosine kinase 2